 | Up a level |
Bissell, Lesley-Anne, Anderson, Marina, Burgess, Malcolm, Chakravarty, Kuntal, Coghlan, Gerry, Dumitru, Raluca B, Graham, Lee, Ong, Voon, Pauling, John D, Plein, Sven et al (show 3 more authors)
(2017)
Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis.
RHEUMATOLOGY, 56 (6).
pp. 912-921.
Sprung, Victoria S 
ORCID: 0000-0002-2666-4986, Kemp, Graham J ORCID: 0000-0002-8324-9666, Wilding, John Ph ORCID: 0000-0003-2839-8404, Adams, Valerie, Murphy, Kieran, Burgess, Malcolm, Emegbo, Stephen, Thomas, Matthew, Needham, Alexander J, Weimken, Andrew et al (show 4 more authors)
(2020)
Randomised, cOntrolled Multicentre trial of 26 weeks subcutaneous liraglutide (a glucagon-like peptide-1 receptor Agonist), with or without contiNuous positive airway pressure (CPAP), in patients with type 2 diabetes mellitus (T2DM) and obstructive sleep apnoEa (OSA) (ROMANCE): study protocol assessing the effects of weight loss on the apnea-hypnoea index (AHI).
BMJ OPEN, 10 (7).
e038856-.
Brown, Emily, Wilton, Moon M ORCID: 0000-0003-4052-7918, Sprung, Victoria S ORCID: 0000-0002-2666-4986, Harrold, Joanne A ORCID: 0000-0002-0899-4586, Halford, Jason CG ORCID: 0000-0003-1629-3189, Stancak, Andrej ORCID: 0000-0003-3323-3305, Burgess, Malcolm, Howarth, Elaine, Umpleby, A Margot, Kemp, Graham J ORCID: 0000-0002-8324-9666 et al (show 2 more authors)
(2021)
A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol.
BMJ open, 11 (7).
e045663-e045663.